⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6706926 | 0.84 | — | — | |
| Succinic Acid SCHEMBL29808469 | 0.80 | — | — | |
| Succinic Acid SCHEMBL21867134 | 0.80 | LMNA (1.00) | — | |
| Succinic Acid SCHEMBL4269130 | 0.80 | LMNA (1.00) | — | |
| Succinic Acid SCHEMBL24696 | 0.80 | LMNA (1.00) | — | |
| Succinic Acid SCHEMBL829 | 0.80 | — | — | |
| Succinic Acid SCHEMBL1331200 | 0.80 | — | — | |
| Succinic Acid SCHEMBL3799615 | 0.80 | — | — | |
| Succinic Acid SCHEMBL4269135 | 0.80 | LMNA (1.00) | — | |
| Succinic Acid SCHEMBL8992010 | 0.80 | LMNA (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7138530-B2 | Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2006-11-21 | — | — | US | claimed |
| EP-1549632-A4 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | DIMENSIONAL PHARM INC (US) | 2005-11-09 | — | — | EP | claimed |
| US-20050234081-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | SUBASINGHE NALIN | 2005-10-20 | — | — | US | claimed |
| EP-1549632-A1 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2005-07-06 | — | — | EP | claimed |
| US-20040009995-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2004-01-15 | — | — | US | claimed |
| WO-2003099805-A1 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2003-12-04 | — | — | WO | claimed |
| US-5210290-A | NMR diagnostic aid | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-05-11 | — | — | US | claimed |
| EP-0266735-B1 | FIBER REACTIVE YELLOW MONOAZO COMPOUND HAVING TWO VINYLSULFONE TYPE GROUPS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-02-06 | — | — | EP | claimed |
| EP-0207474-B1 | SILVER HALIDE PHOTOGRAPHIC MATERIAL | KONICA CORPORATION (JP) | 1990-08-29 | — | — | EP | claimed |
| US-4910298-A | Containing triamine substituted triazole ring | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-03-20 | — | — | US | claimed |
| EP-0266735-A1 | Fiber reactive yellow monoazo compound having two vinylsulfone type groups | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-05-11 | — | — | EP | claimed |
| EP-0207474-A2 | Silver halide photographic material | KONICA CORPORATION (JP) | 1987-01-07 | — | — | EP | claimed |
| US-10358567-B2 | Compound, ink, ink cartridge and ink jet recording method | CANON KABUSHIKI KAISHA (JP) | 2019-07-23 | — | — | US | disclosed |
| US-10190009-B2 | Ink composition, ink jet recording method using same, and colored material | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20170247557-A1 | COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD | CANON KABUSHIKI KAISHA (JP) | 2017-08-31 | — | — | US | disclosed |
| US-9587129-B2 | Ink composition and ink set | SEIKO EPSON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| EP-0000500-A2 | Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-02-07 | — | — | EP | disclosed |
| US-4113867-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1978-09-12 | — | — | US | disclosed |
| US-4041161-A | ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
| US-4001411-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-01-04 | — | — | US | disclosed |